|
PSMD5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.997000E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.457500E-02 |
| Normal-vs-Stage2 |
3.836100E-02 |
| Normal-vs-Stage3 |
2.00049999999896E-05 |
| Normal-vs-Stage4 |
4.966600E-04 |
| Stage1-vs-Stage2 |
4.327000E-01 |
| Stage1-vs-Stage3 |
2.704900E-03 |
| Stage1-vs-Stage4 |
2.174500E-02 |
| Stage2-vs-Stage3 |
2.734400E-01 |
| Stage2-vs-Stage4 |
4.971400E-01 |
| Stage3-vs-Stage4 |
6.603400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.645100E-04 |
| Normal-vs-AfricanAmerican |
7.033100E-04 |
| Normal-vs-Asian |
7.421400E-01 |
| Caucasian-vs-AfricanAmerican |
3.750800E-01 |
| Caucasian-vs-Asian |
4.266200E-01 |
| AfricanAmerican-vs-Asian |
2.064600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.843800E-04 |
| Normal-vs-Female |
5.835100E-04 |
| Male-vs-Female |
6.018200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.853900E-02 |
| Normal-vs-Age(41-60Yrs) |
6.538800E-03 |
| Normal-vs-Age(61-80Yrs) |
3.594900E-04 |
| Normal-vs-Age(81-100Yrs) |
3.442600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.697000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.730600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.202000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.895810E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.181400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.326000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.939000E-01 |
| Normal-vs-Grade 2 |
4.238100E-02 |
| Normal-vs-Grade 3 |
4.09740000000269E-05 |
| Normal-vs-Grade 4 |
2.44859999999347E-05 |
| Grade 1-vs-Grade 2 |
2.879000E-01 |
| Grade 1-vs-Grade 3 |
2.139900E-02 |
| Grade 1-vs-Grade 4 |
1.626120E-02 |
| Grade 2-vs-Grade 3 |
8.797200E-03 |
| Grade 2-vs-Grade 4 |
2.297000E-03 |
| Grade 3-vs-Grade 4 |
1.684010E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.498200E-01 |
| Normal-vs-ccB subtype |
2.40349999999223E-05 |
| ccA subtype-vs-ccB subtype |
2.19429999999132E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.628400E-04 |
| Normal-vs-N1 |
1.229800E-02 |
| N0-vs-N1 |
5.052400E-01 |
|
|
